
Cohance Lifesciences Investor Relations Material
Latest events

Q4 24/25
Cohance Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cohance Lifesciences Limited
Access all reports
Suven Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs) and intermediates. The company primarily focuses on contract development and manufacturing services (CDMO) for global pharmaceutical companies, supporting drug discovery and commercial production. Its operations include process research, custom synthesis, and scale-up of complex molecules for use in various therapeutic areas. Suven Pharmaceuticals Limited serves clients across regulated and emerging markets. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
COHANCE
Country
🇮🇳 India